New research from the Center for Drug Discovery at Northeastern presents a series of molecules that can be controllably deactivated, thereby reducing the side effects of potentially valuable drugs.
The Center for Drug Discovery at Northeastern hosted the 10th annual symposium on current trends in drug-abuse research earlier this month.
Alexandros Makriyannis, the founding director of Northeastern’s Center for Drug Discovery, has received the annual Award in Medicinal Chemistry from the American Chemical Society.
A delegation of Algerian government officials met last week with President Joseph E. Aoun and faculty members in the Bouvé College of Health Sciences with the hope of forging partnerships in the biotechnology sector.
Northeastern’s Center for Drug Discovery collaborates with National Institutes of Health on a therapeutic drug that could aid weight loss without side effects
Northeastern University Pharmaceutical Sciences professor and Center for Drug Discovery director Alexandros Makriyannis and a team of researchers have created a synthetic molecule that could be used to treat chronic […]
(with Wood J.T., J.S. Williams, L. Pandarinathan, D.R. Janero, and C.J. Lammi-Keefe) J. Lipid Res., 51(6), 1416-1423.
(with Zvonok N., W. Xu, J. Williams, D.R. Janero, and S.C. Krishnan) J. Proteome Res., 9(4), 1746-1753.
(with Cluny N.L., A.P. Chambers, V.K. Vemuri, J.T. Wood, L.K. Eller, C. Freni, R.A. Reimer, and K.A. Sharkey) Pharmacol. Biochem. Behav., 97(3), 537-543.